Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
  1. 4 Open-market buy Chief Medical Officer bought 1,389 shares at $7.20 ($10,001)
  2. 4 Open-market buy Chief Commercial Officer bought 1,000 shares at $7.23 ($7,227)
  3. 4 Open-market buy Chief Financial Officer bought 100 shares at $7.12 ($712)
  4. 4 Open-market buy Chief Executive Officer bought 995 shares at $6.99 ($6,955)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Director bought 2,000 shares at $6.98 ($13,958)
  8. 4 Open-market buy Director bought 1,000 shares at $6.98 ($6,978)
  9. 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $6.85 ($34,259)
  10. 4 Open-market buy Chief Medical Officer bought 4,638 shares at $6.47 ($29,994)
  11. 4 Open-market buy Chief Financial Officer bought 1,500 shares at $6.67 ($10,005)
  12. 4 Open-market buy Chief Executive Officer bought 1,530 shares at $6.49 ($9,930)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Exercise or conversion President and CSO acquired 10,000 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 9 of 17 · 340 filings